These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 35255350)

  • 21. PTP1b Inhibition, A Promising Approach for the Treatment of Diabetes Type II.
    Eleftheriou P; Geronikaki A; Petrou A
    Curr Top Med Chem; 2019; 19(4):246-263. PubMed ID: 30714526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in protein tyrosine phosphatase 1B inhibitors.
    Taylor SD; Hill B
    Expert Opin Investig Drugs; 2004 Mar; 13(3):199-214. PubMed ID: 15013940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small molecules as potent protein tyrosine phosphatase 1B (PTP1B) inhibitors documented in patents from 2009 to 2013.
    Wang LJ; Jiang B; Wu N; Wang SY; Shi DY
    Mini Rev Med Chem; 2015; 15(2):104-22. PubMed ID: 25643610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PTP1B inhibitors for type 2 diabetes treatment: a patent review (2011 - 2014).
    Tamrakar AK; Maurya CK; Rai AK
    Expert Opin Ther Pat; 2014 Oct; 24(10):1101-15. PubMed ID: 25120222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pyrazoles as novel protein tyrosine phosphatase 1B (PTP1B) inhibitors: An in vitro and in silico study.
    Rocha S; Lucas M; Silva VLM; Gomes PMO; Silva AMS; Araújo AN; Aniceto N; Guedes RC; Corvo ML; Fernandes E; Freitas M
    Int J Biol Macromol; 2021 Jun; 181():1171-1182. PubMed ID: 33857515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can Allostery Be a Key Strategy for Targeting PTP1B in Drug Discovery? A Lesson from Trodusquemine.
    Maccari R; Ottanà R
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological inhibition of protein tyrosine phosphatase 1B: a promising strategy for the treatment of obesity and type 2 diabetes mellitus.
    Panzhinskiy E; Ren J; Nair S
    Curr Med Chem; 2013; 20(21):2609-25. PubMed ID: 23627940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein tyrosine phosphatase 1B as a target for the treatment of impaired glucose tolerance and type II diabetes.
    Liu G; Trevillyan JM
    Curr Opin Investig Drugs; 2002 Nov; 3(11):1608-16. PubMed ID: 12476961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein tyrosine phosphatase 1B (PTP1B) inhibitors as potential anti-diabetes agents: patent review (2015-2018).
    Hussain H; Green IR; Abbas G; Adekenov SM; Hussain W; Ali I
    Expert Opin Ther Pat; 2019 Sep; 29(9):689-702. PubMed ID: 31402706
    [No Abstract]   [Full Text] [Related]  

  • 30. A potent, selective, and orally bioavailable inhibitor of the protein-tyrosine phosphatase PTP1B improves insulin and leptin signaling in animal models.
    Krishnan N; Konidaris KF; Gasser G; Tonks NK
    J Biol Chem; 2018 Feb; 293(5):1517-1525. PubMed ID: 29217773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and synthesis of imidazolidine-2,4-dione derivatives as selective inhibitors by targeting protein tyrosine phosphatase-1B over T-cell protein tyrosine phosphatase.
    Ma Y; Sun SX; Cheng XC; Wang SQ; Dong WL; Wang RL; Xu WR
    Chem Biol Drug Des; 2013 Nov; 82(5):595-602. PubMed ID: 23848232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of protein tyrosine phosphatase 1B (PTP1B) in the pathogenesis of type 2 diabetes mellitus and its complications.
    Teimouri M; Hosseini H; ArabSadeghabadi Z; Babaei-Khorzoughi R; Gorgani-Firuzjaee S; Meshkani R
    J Physiol Biochem; 2022 May; 78(2):307-322. PubMed ID: 34988903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein tyrosine phosphatase 1B: a new target for the treatment of obesity and associated co-morbidities.
    Ukkola O; Santaniemi M
    J Intern Med; 2002 Jun; 251(6):467-75. PubMed ID: 12028501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitors of protein tyrosine phosphatase 1B (PTP1B).
    Taylor SD
    Curr Top Med Chem; 2003; 3(7):759-82. PubMed ID: 12678843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of protein tyrosine phosphatase 1B in cardiovascular diseases.
    Thiebaut PA; Besnier M; Gomez E; Richard V
    J Mol Cell Cardiol; 2016 Dec; 101():50-57. PubMed ID: 27596049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional properties of Claramine: a novel PTP1B inhibitor and insulin-mimetic compound.
    Qin Z; Pandey NR; Zhou X; Stewart CA; Hari A; Huang H; Stewart AF; Brunel JM; Chen HH
    Biochem Biophys Res Commun; 2015 Feb; 458(1):21-7. PubMed ID: 25623533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Looking at Marine-Derived Bioactive Molecules as Upcoming Anti-Diabetic Agents: A Special Emphasis on PTP1B Inhibitors.
    Ezzat SM; Bishbishy MHE; Habtemariam S; Salehi B; Sharifi-Rad M; Martins N; Sharifi-Rad J
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30558294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein-tyrosine phosphatase 1B substrates and metabolic regulation.
    Bakke J; Haj FG
    Semin Cell Dev Biol; 2015 Jan; 37():58-65. PubMed ID: 25263014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus.
    Koren S; Fantus IG
    Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):621-40. PubMed ID: 18054739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein tyrosine phosphatase 1B (PTP1B) as a potential therapeutic target for neurological disorders.
    Olloquequi J; Cano A; Sanchez-López E; Carrasco M; Verdaguer E; Fortuna A; Folch J; Bulló M; Auladell C; Camins A; Ettcheto M
    Biomed Pharmacother; 2022 Nov; 155():113709. PubMed ID: 36126456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.